Suppr超能文献

持续非卧床腹膜透析——终末期肾病治疗的新维度。

Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.

作者信息

Shohat J, Boner G, Rosenfeld J, Waller A, Iaina A, Eliahou H E

出版信息

Isr J Med Sci. 1982 Oct;18(10):1014-8.

PMID:7174268
Abstract

Thirty-five patients treated with continuous ambulatory peritoneal dialysis (CAPD) were followed over a 2-yr period. Serum levels of protein metabolites were maintained at stable and satisfactory levels. Blood hemoglobin was higher during CAPD treatment than during hemodialysis. At the end of the follow-up period, 45.7% of the patients were still on CAPD, 25.7% of them had been transferred to another mode of dialysis because of complications, and 28.6% of the patients had died. In half of the latter, death was directly related to CAPD. The high incidence of peritonitis (one infection per 2.4 patient months) is the main drawback and reason for mortality in CAPD. Reduction in the incidence of peritonitis would make CAPD the preferred mode of dialytic therapy.

摘要

对35例接受持续性非卧床腹膜透析(CAPD)治疗的患者进行了为期2年的随访。蛋白质代谢产物的血清水平维持在稳定且令人满意的水平。CAPD治疗期间的血红蛋白水平高于血液透析期间。随访期结束时,45.7%的患者仍在接受CAPD治疗,25.7%的患者因并发症已转为其他透析方式,28.6%的患者死亡。在后者中,一半患者的死亡与CAPD直接相关。腹膜炎的高发生率(每2.4个患者月发生一次感染)是CAPD的主要缺点和死亡原因。降低腹膜炎的发生率将使CAPD成为透析治疗的首选方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验